AKT1 and liver cancer: The Akt and ERK signaling pathways were both activated in Akt/N-Ras-induced liver cancers (Ho et al., 2012) and aberrant lipid metabolism was observed in the originally transformed hepatocytes, as well as in the tumor cells (Liu et al., 2018).